Streetbeat News

Earnings

PERF

Perfect Corp projects its total revenue recognized under IFRS for 2024 to grow by 12%-16% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:39 pm

COCO

Vita Coco projects FY24 net sales of $495M-$505M, slightly below the $503.27M estimate. The forecast accounts for growth in coconut water volume but anticipates declines in the coconut oil business and price/mix effects. Gross margin is expected to be 36%-38%, with SG&A expenses roughly equal to 2023. Adjusted EBITDA is predicted to be $74M-$78M, considering potential transportation cost increases due to higher ocean freight rates.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:38 pm

IMCR

Immunocore Holdings reported Q4 GAAP EPS of $(0.40), missing the $(0.28) estimate, but sales of $67.59M exceeded the $67.23M forecast. This represents a 36.51% decrease in losses and a 34.05% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:38 pm

EME

EMCOR projects its full-year 2024 revenues to range between $13.5 billion and $14.0 billion, surpassing the consensus estimate of $13.46 billion. The company also forecasts its 2024 EPS to be between $14.00 and $15.00, exceeding the consensus of $13.3.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:38 pm

LIND

Lindblad Expeditions (NASDAQ:LIND) reported Q4 earnings with a loss of $(0.53) per share, missing the $(0.28) estimate, and sales of $125.36M, missing the $127.27M estimate. This represents a 15.87% improvement in losses and a 6.27% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:37 pm

DAKT

Daktronics anticipates its Q4 net sales to rise sequentially but to fall compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:37 pm

TPB

Turning Point Brands projects its adjusted EBITDA for fiscal year 2024 to be between $95 million and $100 million.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:37 pm

APG

APi Group has announced its Q1 2024 sales outlook, projecting net revenues of $1.56B to $1.61B, which is below the $1.66B estimate. The company also expects adjusted EBITDA to be between $165M and $180M.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:36 pm

SNSE

Sensei Biotherapeutics reported a narrower FY EPS loss of $(1.22), improving from $(1.58) YoY. The company expects its $65.8M in cash and securities to last until Q4 2025.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:36 pm

APG

APi Group has announced its FY2024 guidance, projecting net revenues between $7.05B and $7.25B, adjusted EBITDA between $855M and $905M, and an adjusted free cash flow conversion rate of approximately 70%.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:35 pm